N-Me-DL-Ala-OH

N-Me-DL-Ala-OH is a methylated alanine derivative in which the amino group is N-methylated, producing a chiral amino acid framework with a free carboxylic acid and a secondary amide-like nitrogen environment. The DL stereochemical designation indicates racemic composition at the alanine stereocenter, enabling stereochemical matching or deliberate use of mixed stereochemistry in synthetic planning. The molecule contains a primary carboxylic acid functionality for coupling chemistry and an N-methylated nitrogen that modulates nucleophilicity and peptide-bond formation behavior relative to unmodified alanine. As an amino acid building block and chiral/achiral intermediate, N-Me-DL-Ala-OH can be converted into protected derivatives for controlled incorporation into peptide chains, as well as transformed into downstream functionalized intermediates for amino acid derivatization workflows.

1. Peptide Synthesis

N-Me-DL-Ala-OH is applied in peptide building-block preparation where alanine-based residues are required with N-methylated backbone character. The free carboxylic acid enables activation for amide bond formation, while the N-methylated amino group supports incorporation of N-methyl alanine motifs that influence backbone conformation and proteolytic stability in peptide analogs. Protecting-group strategies typically involve temporary masking of the carboxyl group (as an ester) and/or conversion of the acid to an activated coupling form, followed by compatibility with standard peptide coupling conditions used for amino acid derivatives. The resulting N-methylated peptide fragments can be used to construct peptide libraries, generate conformationally restricted analogs, and support peptide science studies where amino acid backbone modification is a key design variable.

2. Peptidomimetics Research

N-Me-DL-Ala-OH is used in peptidomimetic construction and molecular scaffold design where N-methyl substitution is leveraged to tune hydrogen-bonding patterns and amide geometry. The alanine side chain provides a simple alkyl handle for controlled steric and electronic effects, while the N-methylated nitrogen changes the donor/acceptor profile of the peptide backbone when incorporated into larger structures. Racemic stereochemistry can be used to access both stereochemical variants in early-stage SAR exploration or to generate mixtures for analytical method development prior to stereoselective resolution. Downstream derivatives prepared from N-Me-DL-Ala-OH can feed into fragment assembly, library synthesis, and conformational mapping studies that rely on amino acid-based backbone modifications.

3. Amino Acid Derivatization

N-Me-DL-Ala-OH serves as a direct precursor for amino acid derivatization chemistry targeting carboxyl-activated intermediates and N-methylated functional motifs. The free carboxylic acid can be converted into coupling-ready species or functionalized esters and amides, while the N-methylated nitrogen can undergo further transformations such as selective protection, activation, or incorporation into heteroatom-containing derivatives depending on the desired downstream functionality. DL stereochemistry supports synthetic flexibility when stereochemical purity is not required, enabling route screening for protected amino acid synthesis and intermediate preparation. The derivative products generated from N-Me-DL-Ala-OH can be used as intermediates in fine chemical synthesis and as building blocks for constructing larger chiral or achiral molecules.

4. Chemical Manufacturing Intermediates

N-Me-DL-Ala-OH is relevant to process chemistry intermediate preparation where methylated amino acid building blocks are used to control amide formation characteristics and downstream purification profiles. The combination of a stable N-methylated amino functionality with a free carboxylic acid provides a practical handle for converting into protected amino acid derivatives that can be fed into sequential synthesis steps. Industrially, the compound can be employed in the manufacture of N-methylated peptide fragments, amino acid ester intermediates, and activated acid derivatives used in multi-step manufacturing routes for specialty chemicals. The racemic nature can be advantageous in process development phases where stereochemical resolution is deferred to later stages or where mixed stereochemistry is acceptable for the targeted intermediate.

5. Analytical Standards Development

N-Me-DL-Ala-OH is suitable for analytical research and method development where defined amino acid standards are required to monitor derivatization, coupling, and decomposition pathways. The presence of both a free carboxylic acid and an N-methylated nitrogen yields a distinct chromatographic and spectroscopic signature compared with unmodified alanine, supporting identification of N-methyl alanine residues in reaction mixtures. DL stereochemistry can be leveraged for calibration of total N-methyl alanine content when enantiomer-specific separation is not required, while protected derivatives generated from the compound can serve as internal standards for peptide hydrolysis or derivatization workflows. Downstream analytical utility extends to quality control of amino acid derivative syntheses and verification of N-methylated backbone incorporation in peptide-building-block preparations.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

3. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function